JHM is committed to becoming
a global leader in synthetic biology
Continuously broadening the applications of recombinant protein drugs and products in healthcare applications thereby creating exceptional value for human health.
JHM Biopharmaceutical (Hangzhou) Co., Ltd.（hereinafter referred to as “JHM”) is an innovative biopharmaceutical company, we are committed to advancing protein-based drugs and medical devices through recombinant technology. Our core business focuses on three major areas: the treatment of endocrine and neurological disorders, as well as tissue repair.
JHM adheres to a patient-centered approach, driven by technological innovation. The company focuses on healthcare applications, accelerating the development of its product pipeline and striving for industry leadership in the field of recombinant protein drugs.
Dr. Leng Chunsheng, Founder
